14.40
+0.96
+(7.14%)
As of 3:29:02 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 3 | 7 | 7 |
| Avg. Estimate | 9.87M | 2.17M | 20.97M | 38.11M |
| Low Estimate | -- | -- | 11.14M | -- |
| High Estimate | 35M | 3.5M | 46.14M | 205M |
| Year Ago Sales | 12.09M | 4.91M | 25.18M | 20.97M |
| Sales Growth (year/est) | -18.35% | -55.84% | -16.70% | 81.69% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4LN2.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/2/2025 |
| Initiated | Jones Trading: Buy | 11/18/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/2/2024 |
| Initiated | Oppenheimer: Outperform | 5/17/2024 |
Related Tickers
2LB.BE Iovance Biotherapeutics Inc
5.99
+0.67%
2LB.F Iovance Biotherapeutics, Inc.
5.99
+0.77%
MOOD.CN Doseology Sciences Inc.
0.1200
0.00%
IFRX InflaRx N.V.
2.4314
+2.58%
SLRX Salarius Pharmaceuticals, Inc.
2.2500
+4.65%
AUTL Autolus Therapeutics plc
2.2250
+1.14%
CABA Cabaletta Bio, Inc.
2.4550
+4.92%
CTXR Citius Pharmaceuticals, Inc.
2.7100
-4.24%
CRDF Cardiff Oncology, Inc.
4.0550
+2.14%
HOTH Hoth Therapeutics, Inc.
1.3200
+3.13%